CH Biomedical
Latest round
- Series D
Last raised
- Jan 2022
Total raised
- Undisclosed
Investors
- 19
About CH Biomedical
Founded in 2008 and based in Suzhou, China, CH Biomedical was established by a team of overseas experts in cardiac device development.S., is based in Los Angeles, California. In 2021, its CH-VAD device became the first domestically approved fully magnetically levitated artificial heart in China. CH Biomedical has regularly presented at the International Society for Mechanical Circulatory Support and other global academic conferences. In 2020, the Texas Heart Institute conducted a GLP-compliant preclinical study on CH-VAD. Dr. Feng Lin, the company’s co-founder and CTO, previously worked at Kriton Medical. The company engages in the development of artificial heart assist devices. Its main product is a full magnetic levitation blood pump artificial heart CH-VAD. The full magnetic levitation blood pump artificial heart CH-VAD has the function of pumping blood to the human circulatory system to assist or replace the natural heart. The CH-VAD is a new generation of fully magnetically levitated artificial heart, by rotating the vane rotor to create negative pressure in the center of the blood pump rotor to pump the patient's left ventricular blood to the ascending aorta, generating flow in the circulatory system and realizing that the blood pump works in tandem with the natural heart. The company generates revenue through sales of its ventricular assist devices and related medical technology services.
Who invested in CH Biomedical
19 investors across 8 rounds
See all investors in CH Biomedical
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series D
Jan 25, 2022
Amount
Undisclosed
Investors
Series D
Aug 13, 2021
Amount
Undisclosed
Investors
Series C
Dec 28, 2020
Amount
Undisclosed
Investors
Series B
Apr 30, 2020
Amount
Undisclosed
Investors
Series B
Apr 26, 2019
Amount
Undisclosed
Investors
Series A
Feb 26, 2018
Amount
Undisclosed
Investors
Angel
Nov 24, 2016
Amount
Undisclosed
Investors
Angel
Feb 1, 2014
Amount
Undisclosed
Investors
Questions about CH Biomedical
Who invested in CH Biomedical?
CH Biomedical has 19 investors on record across 8 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has CH Biomedical raised?
CH Biomedical has raised 8 venture rounds. Sign up free to see how much each round raised and the total.
When did CH Biomedical last raise money?
CH Biomedical's most recent round on record is a Series D, in Jan 2022.
What does CH Biomedical do?
Founded in 2008 and based in Suzhou, China, CH Biomedical was established by a team of overseas experts in cardiac device development.
Where is CH Biomedical headquartered?
CH Biomedical is headquartered in Suzhou, China.
Which VCs invest in companies like CH Biomedical?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back medical devices & equipment companies at CH Biomedical's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series D
Raising like CH Biomedical? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.